These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

228 related items for PubMed ID: 23026237

  • 1. Construction, expression, and characterization of an anti-tumor immunotoxin containing the human anti-c-Met single-chain antibody and PE38KDEL.
    Liu Z, Feng Z, Zhu X, Xu W, Zhu J, Zhang X, Fan Z, Ji G.
    Immunol Lett; 2013 Jan; 149(1-2):30-40. PubMed ID: 23026237
    [Abstract] [Full Text] [Related]

  • 2. Phage display-based generation of novel internalizing antibody fragments for immunotoxin-based treatment of acute myeloid leukemia.
    Fitting J, Blume T, Ten Haaf A, Blau W, Gattenlöhner S, Tur MK, Barth S.
    MAbs; 2015 Jan; 7(2):390-402. PubMed ID: 25760770
    [Abstract] [Full Text] [Related]

  • 3. Recombinant CD64-specific single chain immunotoxin exhibits specific cytotoxicity against acute myeloid leukemia cells.
    Tur MK, Huhn M, Thepen T, Stöcker M, Krohn R, Vogel S, Jost E, Osieka R, van de Winkel JG, Fischer R, Finnern R, Barth S.
    Cancer Res; 2003 Dec 01; 63(23):8414-9. PubMed ID: 14679004
    [Abstract] [Full Text] [Related]

  • 4. Recombinant anti-podoplanin (NZ-1) immunotoxin for the treatment of malignant brain tumors.
    Chandramohan V, Bao X, Kato Kaneko M, Kato Y, Keir ST, Szafranski SE, Kuan CT, Pastan IH, Bigner DD.
    Int J Cancer; 2013 May 15; 132(10):2339-48. PubMed ID: 23115013
    [Abstract] [Full Text] [Related]

  • 5. Preclinical evaluation of a recombinant anti-prostate specific membrane antigen single-chain immunotoxin against prostate cancer.
    Wolf P, Alt K, Wetterauer D, Bühler P, Gierschner D, Katzenwadel A, Wetterauer U, Elsässer-Beile U.
    J Immunother; 2010 Apr 15; 33(3):262-71. PubMed ID: 20445346
    [Abstract] [Full Text] [Related]

  • 6. In vivo efficacy of the recombinant anti-CD64 immunotoxin H22(scFv)-ETA' in a human acute myeloid leukemia xenograft tumor model.
    Tur MK, Huhn M, Jost E, Thepen T, Brümmendorf TH, Barth S.
    Int J Cancer; 2011 Sep 01; 129(5):1277-82. PubMed ID: 21077160
    [Abstract] [Full Text] [Related]

  • 7. Target-specific cytotoxic activity of recombinant immunotoxin scFv(MUC1)-ETA on breast carcinoma cells and primary breast tumors.
    Singh R, Samant U, Hyland S, Chaudhari PR, Wels WS, Bandyopadhyay D.
    Mol Cancer Ther; 2007 Feb 01; 6(2):562-9. PubMed ID: 17308054
    [Abstract] [Full Text] [Related]

  • 8. [Construction, expression and functional characterization of disulfide-stabilized anti-hepatocarcinoma single chain Fv fused with truncated Pseudomonas exotoxin].
    Zhao J, Sun ZW, Liu YF, Yu WY.
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2003 Nov 01; 19(6):585-7. PubMed ID: 15182657
    [Abstract] [Full Text] [Related]

  • 9. Bivalent disulfide-stabilized fragment variable immunotoxin directed against mesotheliomas and ovarian cancer.
    Bera TK, Williams-Gould J, Beers R, Chowdhury P, Pastan I.
    Mol Cancer Ther; 2001 Dec 01; 1(2):79-84. PubMed ID: 12467225
    [Abstract] [Full Text] [Related]

  • 10. Affitoxin--a novel recombinant, HER2-specific, anticancer agent for targeted therapy of HER2-positive tumors.
    Zielinski R, Lyakhov I, Jacobs A, Chertov O, Kramer-Marek G, Francella N, Stephen A, Fisher R, Blumenthal R, Capala J.
    J Immunother; 2009 Oct 01; 32(8):817-25. PubMed ID: 19752752
    [Abstract] [Full Text] [Related]

  • 11. A recombinant immunotoxin engineered for increased stability by adding a disulfide bond has decreased immunogenicity.
    Liu W, Onda M, Kim C, Xiang L, Weldon JE, Lee B, Pastan I.
    Protein Eng Des Sel; 2012 Jan 01; 25(1):1-6. PubMed ID: 22101015
    [Abstract] [Full Text] [Related]

  • 12. Cytotoxic and antitumor activity of a recombinant immunotoxin composed of disulfide-stabilized anti-Tac Fv fragment and truncated Pseudomonas exotoxin.
    Reiter Y, Kreitman RJ, Brinkmann U, Pastan I.
    Int J Cancer; 1994 Jul 01; 58(1):142-9. PubMed ID: 8014011
    [Abstract] [Full Text] [Related]

  • 13. Efficient targeting of CD13 on cancer cells by the immunotoxin scFv13-ETA' and the bispecific scFv [13xds16].
    Grieger E, Gresch G, Niesen J, Woitok M, Barth S, Fischer R, Fendel R, Stein C.
    J Cancer Res Clin Oncol; 2017 Nov 01; 143(11):2159-2170. PubMed ID: 28669053
    [Abstract] [Full Text] [Related]

  • 14. Mechanisms of Resistance to Immunotoxins Containing Pseudomonas Exotoxin A in Cancer Therapy.
    Dieffenbach M, Pastan I.
    Biomolecules; 2020 Jun 30; 10(7):. PubMed ID: 32630017
    [Abstract] [Full Text] [Related]

  • 15. Construction, expression, and activity of a novel immunotoxin comprising a humanized antiepidermal growth factor receptor scFv and modified Pseudomonas aeruginosa exotoxin A.
    Akbari B, Farajnia S, Zarghami N, Mahdieh N, Rahmati M, Khosroshahi SA, Barzegar A, Rahbarnia L.
    Anticancer Drugs; 2017 Mar 30; 28(3):263-270. PubMed ID: 27861173
    [Abstract] [Full Text] [Related]

  • 16. Expression of VGRNb-PE immunotoxin in transplastomic lettuce (Lactuca sativa L.).
    Mirzaee M, Jalali-Javaran M, Moieni A, Zeinali S, Behdani M.
    Plant Mol Biol; 2018 May 30; 97(1-2):103-112. PubMed ID: 29633168
    [Abstract] [Full Text] [Related]

  • 17. A protease-resistant immunotoxin against CD22 with greatly increased activity against CLL and diminished animal toxicity.
    Weldon JE, Xiang L, Chertov O, Margulies I, Kreitman RJ, FitzGerald DJ, Pastan I.
    Blood; 2009 Apr 16; 113(16):3792-800. PubMed ID: 18988862
    [Abstract] [Full Text] [Related]

  • 18. Combination of the PI3K inhibitor ZSTK474 with a PSMA-targeted immunotoxin accelerates apoptosis and regression of prostate cancer.
    Baiz D, Hassan S, Choi YA, Flores A, Karpova Y, Yancey D, Pullikuth A, Sui G, Sadelain M, Debinski W, Kulik G.
    Neoplasia; 2013 Oct 16; 15(10):1172-83. PubMed ID: 24204196
    [Abstract] [Full Text] [Related]

  • 19. Engineered Anti-GPC3 Immunotoxin, HN3-ABD-T20, Produces Regression in Mouse Liver Cancer Xenografts Through Prolonged Serum Retention.
    Fleming BD, Urban DJ, Hall MD, Longerich T, Greten TF, Pastan I, Ho M.
    Hepatology; 2020 May 16; 71(5):1696-1711. PubMed ID: 31520528
    [Abstract] [Full Text] [Related]

  • 20. Soluble Cytoplasmic Expression and Purification of Immunotoxin HER2(scFv)-PE24B as a Maltose Binding Protein Fusion.
    Park S, Nguyen MQ, Ta HKK, Nguyen MT, Lee G, Kim CJ, Jang YJ, Choe H.
    Int J Mol Sci; 2021 Jun 17; 22(12):. PubMed ID: 34204265
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.